Summit expands its offering with soft chew formulations

For more than a decade, Summit Veterinary Pharmaceuticals has supported veterinary surgeons with high-quality veterinary specials designed to help address otherwise unmet patient needs. By understanding patients and the realities faced by owners, Summit helps veterinary surgeons make individualised treatment plans more achievable. The addition of soft chews further expands Summit’s range of available dosage forms, which already includes tablets, oral liquids and reconstitutes, transdermal gels, powders and oral pastes, alongside flavoured options.

The owner’s ability to administer medication is often an overlooked factor in achieving successful treatment outcomes. Even the most effective treatment only works if given consistently and as prescribed, making ease of administration an important consideration in the real world.

“Joining the Swedencare family has given us access to its globally patented soft chew technology, as well as valuable insights from colleagues with extensive experience in these formulations. Their knowledge has complemented the expertise within our own team as we worked to expand our manufacturing capabilities and bring this exciting dosage form to market”, says Owain Hughes, Operations Director at Summit.

This has been a collaborative journey with the goal of creating a highly palatable product, without compromising the active ingredient. Developing a pharmaceutical product in a soft chew format presents unique challenges, requiring careful balancing of acceptance factors (aroma, flavour, texture) with the formulation of a stable, consistent product. Throughout the process, the focus has remained firmly on maintaining the quality that clinicians expect.

The introduction of this dosage form opens new possibilities for veterinary pharmaceutical delivery. Soft chews offer a practical alternative where traditional administration methods may present challenges, helping to reduce barriers to treatment and support better compliance.

This expansion reflects Summit’s continued focus on identifying and addressing unmet treatment needs among veterinary patients. Every patient is different, and expanding the range of formulations available gives clinicians greater flexibility to tailor treatment decisions to the individual patient and the practical realities faced by owners. The introduction of soft chew formulations represents another step in Summit’s commitment to supporting veterinary surgeons in delivering the best possible care, creating better treatment experiences and improving outcomes for patients.

For more information, please contact:
Rachel Bell, Head of Commercial
Rachel.Bell@svprx.co.uk

Established in 2010 Summit UK offers an extensive suite of animal health specials in the UK and joined Swedencare in 2025. The company maintains 150+ SKU’s and various dosage forms including but not limited to oral pastes, oral solutions, oral suspensions, powders, sublinguals, tablets and transdermal gels. Summit supports a variety of species through its medications including canine, feline, equine and other companion animals. Summit enables over 5.500 veterinary clinics to provide care to its patients across the UK through its 22,500sq ft turn key facilities in Oxford.